We aimed to investigate associations between serum thyroid stimulating hormone (TSH) levels and both severity and outcome after ischemic stroke (IS). A total of 731 patients consecutive IS patients were enrolled (mean age 69.4 ± 15.4, 61.6% men), and serum TSH levels were measured at admission and analyzed according to the tertiles of their distribution (<0.822 vs. 0.822-1.6 vs. >1.6 mUI/l). Associations between TSH and both severity at admission (National Institutes of Health Stroke Scale (NIHSS) scores <5 vs. ≥5) and functional outcome at discharge assessed by the modified Rankin Scale were analyzed using logistic regression and ordinal logistic regression models, respectively. High TSH levels were independently associated with both a decreased risk of NIHSS score ≥5 at admission (prevalence proportion ratio = 0.62; 95% CI 0.41-0.94, p = 0.024 for tertile 3 vs. tertile 1). In addition, patients with high TSH levels had a better functional outcome at discharge (OR 0.43; 95% CI 0.30-0.60, p < 0.001 for tertile 2 vs. tertile 1; OR 0.39; 95% CI 0.27-0.56, p < 0.001 for tertile 3 vs. tertile 1). The mechanisms underlying these associations and their potential exploitation in terms of therapeutic strategies need to be explored.

Keywords:
Stroke, Severity, Stroke outcome, Thyroid hormones, Prognosis
1.
Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A: The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 1999;84:561-566.
2.
Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR: Serum TSH and total T4 in the United States population and their association with participant characteristics: national health and nutrition examination survey (NHANES 1999-2002). Thyroid 2007;17:1211-1223.
3.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-534.
4.
Chaker L, Baumgartner C, Ikram MA, Dehghan A, Medici M, Visser WE, Hofman A, Rodondi N, Peeters RP, Franco OH: Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis. Eur J Epidemiol 2014;29:791-800.
5.
Zhang Y, Meyer MA: Clinical analysis on alteration of thyroid hormones in the serum of patients with acute ischemic stroke. Stroke Res Treat 2010;pii:290678.
6.
Ambrosius W, Kazmierski R, Gupta V, Warot AW, Adamczewska-Kociałkowska D, Błazejewska A, Ziemnicka K, Nowinski WL: Low free triiodothyronine levels are related to poor prognosis in acute ischemic stroke. Exp Clin Endocrinol Diabetes 2011;119:139-143.
7.
Baek JH, Chung PW, Kim YB, Moon HS, Suh BC, Jin DK, Kim BM, Rhee EJ, Lee YT, Park KY: Favorable influence of subclinical hypothyroidism on the functional outcomes in stroke patients. Endocr J 2010;57:23-29.
8.
Alevizaki M, Synetou M, Xynos K, Alevizaki CC, Vemmos KN: Hypothyroidism as a protective factor in acute stroke patients. Clin Endocrinol (Oxf) 2006;65:369-372.
9.
Akhoundi FH, Ghorbani A, Soltani A, Meysamie A: Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidism. Neurology 2011;77:349-354.
10.
World Health Organization: The World Health Report, 2000. Health Systems Improving Performance. Geneva, WHO, 2000.
11.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35-41.
12.
Skov T, Deddens J, Petersen MR, Endahl L: Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol 1998;27:91-95.
13.
Wollenweber FA, Zietemann V, Gschwendtner A, Opherk C, Dichgans M: Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke. Stroke 2013;44:1446-1448.
14.
Forti P, Maioli F, Coveri M, Nativio V, Arnone G, Loreti A, Zoli M, Sacquegna T, Procaccianti G: Thyroid function tests and early outcomes of acute ischemic stroke in older euthyroid patients. Exp Gerontol 2015;61:8-14.
15.
Boucai L, Surks MI: Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf) 2009;70:788-793.
16.
Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509.
17.
Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F: Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003;88:3731-3737.
18.
Pantos C, Mourouzis C, Katramadou M, Saranteas T, Mourouzis I, Karageorgiou H, Tesseromatis C, Kostopanagiotou G, Asimacopoulos P, Cokkinos DV: Decreased vascular reactivity to alpha1 adrenergic stimulation in the presence of hypothyroid state: a part of an adaptive response? Int Angiol 2006;25:216-220.
19.
Ovbiagele B, Saver JL: Day-90 acute ischemic stroke outcomes can be derived from early functional activity level. Cerebrovasc Dis 2010;29:50-56.
20.
Lourbopoulos A, Mourouzis I, Karapanayiotides T, Nousiopoulou E, Chatzigeorgiou S, Mavridis T, Kokkinakis I, Touloumi O, Irinopoulou T, Chouliaras K, Pantos C, Karacostas D, Grigoriadis N: Changes in thyroid hormone receptors after permanent cerebral ischemia in male rats. J Mol Neurosci 2014;54:78-91.
21.
Schwarz S, Schwab S, Klinga K, Maser-Gluth C, Bettendorf M: Neuroendocrine changes in patients with acute space occupying ischaemic stroke. J Neurol Neurosurg Psychiatry 2003;74:725-727.
22.
Gartner W, Weissel M: Do iodine-containing contrast media induce clinically relevant changes in thyroid function parameters of euthyroid patients within the first week? Thyroid 2004;14:521-524.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.